Search Results - "Joshi, Samit"

Refine Results
  1. 1
  2. 2

    Viral Drug Resistance through 48 Weeks, in a Phase 2b, Randomized, Controlled Trial of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir by Lataillade, Max, Zhou, Nannan, Joshi, Samit R, Lee, Sangil, Stock, David A, Hanna, George J, Krystal, Mark

    “…ABSTRACT [Journal limit250 words, currently 250] BACKGROUND:Fostemsavir is a prodrug of temsavir, an attachment inhibitor that binds to HIV-1 gp120, blocking…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Dysregulation of human Toll-like receptor function in aging by Shaw, Albert C, Panda, Alexander, Joshi, Samit R, Qian, Feng, Allore, Heather G, Montgomery, Ruth R

    Published in Ageing research reviews (01-07-2011)
    “…Research highlights ► Dysregulation of Toll-like receptor function occurs in aging humans. ► Adjustment for potential confounding factors is critical in human…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study by Dicker, Ira, Zhang, Sharon, Ray, Neelanjana, Beno, Brett R, Regueiro-Ren, Alicia, Joshi, Samit, Cockett, Mark, Krystal, Mark, Lataillade, Max

    Published in PloS one (17-10-2019)
    “…GSK3532795 (formerly BMS955176) is a second-generation maturation inhibitor (MI) that progressed through a Phase 2b study for treatment of HIV-1 infection…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Multiple network-constrained regressions expand insights into influenza vaccination responses by Avey, Stefan, Mohanty, Subhasis, Wilson, Jean, Zapata, Heidi, Joshi, Samit R, Siconolfi, Barbara, Tsang, Sui, Shaw, Albert C, Kleinstein, Steven H

    Published in Bioinformatics (Oxford, England) (15-07-2017)
    “…Systems immunology leverages recent technological advancements that enable broad profiling of the immune system to better understand the response to infection…”
    Get full text
    Journal Article
  13. 13

    Relative Bioavailability and Food Effect of GSK3640254 Tablet and Capsule Formulations in Healthy Participants by Johnson, Mark, Pene Dumitrescu, Teodora, Joshi, Samit R., Mathew, Ashwin, Bainbridge, Veronica, Zhan, Joyce, Lataillade, Max

    Published in Clinical pharmacology in drug development (01-05-2022)
    “…GSK3640254 is a next‐generation maturation inhibitor with demonstrated potency across HIV‐1 subtypes and a high barrier to emergent resistance. This phase I,…”
    Get full text
    Journal Article
  14. 14

    Exploring HIV-1 Maturation: A New Frontier in Antiviral Development by McGraw, Aidan, Hillmer, Grace, Medehincu, Stefania M, Hikichi, Yuta, Gagliardi, Sophia, Narayan, Kedhar, Tibebe, Hasset, Marquez, Dacia, Mei Bose, Lilia, Keating, Adleigh, Izumi, Coco, Peese, Kevin, Joshi, Samit, Krystal, Mark, DeCicco-Skinner, Kathleen L, Freed, Eric O, Sardo, Luca, Izumi, Taisuke

    Published in Viruses (06-09-2024)
    “…HIV-1 virion maturation is an essential step in the viral replication cycle to produce infectious virus particles. Gag and Gag-Pol polyproteins are assembled…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effects of the HIV‐1 maturation inhibitor GSK3640254 on QT interval in healthy participants by Zhang, Ying, Bush, Mark, Yazdani, Parto, Zhan, Joyce, Wen, Bo, Bainbridge, Veronica, Wynne, Brian R., Joshi, Samit, Lataillade, Max

    Published in Pharmacology research & perspectives (01-12-2023)
    “…GSK3640254 (GSK'254) is a novel HIV‐1 maturation inhibitor with pharmacokinetics supporting once‐daily (QD) therapy for HIV‐1 treatment. This thorough…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Multicolor Digital Flow Cytometry in Human Translational Immunology by Joshi, Samit R, Mohanty, Subhasis, Shaw, Albert C

    “…By facilitating the simultaneous analysis of parameters from diverse cell lineages and biological pathways, multicolor flow cytometry is integral to many…”
    Get more information
    Journal Article